$120.79
+0.18 (+0.15%)
Performance
1D
+0.00%
1W
-6.39%
1M
-20.56%
3M
-3.28%
6M
+114.89%
1Y
+299.04%
YTD
+272.92%
Open$123.83
Previous Close$120.61
Day High$130.90
Day Low$116.50
52W High$219.71
52W Low$23.30
Volume—
Avg Volume2.34M
Market Cap7.69B
P/E Ratio—
EPS$-2.22
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$151.35
Below
SMA 200
$91.22
Above
RSI (14)
43.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-40.7% upside
Current
$120.79
$120.79
Target
$71.60
$71.60
$49.68
$71.60 avg
$88.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 400.86M | 326.57M | 1.46B |
| Net Income | -82,682,785 | -60,622,815 | -327,760,773 |
| Profit Margin | -20.6% | -19.6% | -22.5% |
| EBITDA | -66,594,435 | -51,539,481 | -326,178,396 |
| Free Cash Flow | — | — | -164,017,098 |
| Rev Growth | +22.8% | +22.8% | +7.9% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |